78 A RANDOMIZED PILOT PHASE II STUDY OF THALIDOMIDE AS ADJUVANT THERAPY IN PATIENT WITH HIGH RECURRENCE RISK HEPATOCELLULAR CARCINOMA

M.-C.HoR.-H.HuCHENG-MAW HOC.-N.ChenK.-J.ChangP.-H.Lee2020-02-112020-02-1120110168-8278https://scholars.lib.ntu.edu.tw/handle/123456789/45781778 A RANDOMIZED PILOT PHASE II STUDY OF THALIDOMIDE AS ADJUVANT THERAPY IN PATIENT WITH HIGH RECURRENCE RISK HEPATOCELLULAR CARCINOMAjournal article10.1016/S0168-8278(11)60080-9